Verstat

Alethia Biotherapeutics Inc., based in Montréal, Québec, is focusing on cancer-associated epithelial to mesenchymal transition (EMT) with its clinical-stage monoclonal antibody, AB16B5. This innovative EMT inhibitor is designed to prevent chemotherapy resistance and metastatic tumor invasion in invasive carcinomas. AB16B5 is a humanized IgG2 antibody that effectively blocks EMT, and preclinical data demonstrates its potential to enhance responses to standard chemotherapy while reducing tumor invasion in xenografted animal models. Alethia is committed to advancing this research to improve cancer treatment outcomes. Generated from the website

Prompt Quebec is a service-oriented company based in Montréal, Québec, dedicated to providing efficient maintenance solutions. They offer a comprehensive range of services that ensure optimal performance for their clients' properties and equipment. Their team of skilled professionals is committed to delivering high-quality workmanship and reliable customer service. Leveraging their expertise, Prompt Quebec aims to meet the diverse needs of both residential and commercial clientele in the region. Generated from the website